Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracerebroventricular diphtheria toxin causes off-target toxicity in CD11b-DTR and wild-type mice, revealing limitations of DTR-based depletion studies.

Frontiers in neuroscience·2026
Same author

Non-cell autonomous downregulation of the purinergic receptor P2Y1R promotes neuroprotection after ischemic injury.

Frontiers in cellular neuroscience·2026
Same author

Serious side effects of Alzheimer's immunotherapy demand scrutiny.

Ageing research reviews·2026
Same author

Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway.

Scientific reports·2026
Same author

Anti-amyloid antibodies for Alzheimer's disease are not truly disease modifying.

BMJ (Clinical research ed.)·2026
Same author

Novel floxed cannabinoid receptor 2 mouse line combines knockout capability with dual fluorescent reporters.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: Jun 18, 2026

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
09:37

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Published on: August 31, 2009

Functional heterogeneity at dopamine release sites.

James A Daniel1, Sally Galbraith, Lorraine Iacovitti

  • 1Neuroscience Program, Garvan Institute of Medical Research, Sydney, New South Wales 2010, Australia.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|November 20, 2009
PubMed
Summary
This summary is machine-generated.

Dopamine (DA) neuron synapses have lower release probability than glutamate synapses due to smaller recycling vesicle pools. This study reveals functional heterogeneity in DA neuron synaptic terminals.

More Related Videos

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Related Experiment Videos

Last Updated: Jun 18, 2026

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
09:37

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Published on: August 31, 2009

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Dopamine (DA) neurotransmission is crucial for neurological functions.
  • Mechanisms of synaptic vesicle (SV) release at DA synapses are not well understood.
  • Existing drugs targeting neurological diseases often affect DA synapses.

Purpose of the Study:

  • Investigate synaptic vesicle release mechanisms at single DA synapses.
  • Compare DA synapse release probability (Pr) with glutamatergic hippocampal (Hpc) synapses.
  • Identify factors regulating Pr in DA neurons.

Main Methods:

  • Mathematical modeling of fluorescence loss to analyze SV release.
  • FM 1-43 destaining assays to measure release kinetics.
  • Comparison of DA and Hpc neuron synaptic terminal properties.

Main Results:

  • DA synapses exhibit lower and more variable release probability (Pr) than Hpc synapses.
  • Pr is regulated by the size of the recycling SV pool and a factor reflected in the destaining time constant (tau).
  • DA neurons have smaller recycling SV pools than Hpc neurons, explaining the lower Pr.

Conclusions:

  • DA neuron synaptic terminals are functionally heterogeneous.
  • DA release is less reliable than glutamate release due to a smaller recycling SV pool.
  • Functional nonsynaptic boutons exist in DA axons without altering synaptic function.